Doctors review charts to see how heart drug performs in real life
NCT ID NCT06338202
Summary
This study looked back at medical records to understand how well the medication mavacamten works for people with a specific heart condition called obstructive hypertrophic cardiomyopathy (oHCM) in real-world Canadian clinics. Researchers surveyed doctors and reviewed the charts of 115 adult patients who had already started taking the drug as part of their regular care. The goal was to see if the treatment improved patients' symptoms and heart function outside of a controlled clinical trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (OHCM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
London Health Science Centre (LHSC)
London, Ontario, N6A 5A5, Canada
Conditions
Explore the condition pages connected to this study.